(Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -44.93%292.77M | -43.91%512.67M | -7.68%531.67M | -3.38%914.01M | 92.95%575.89M | -36.39%945.96M | -63.47%298.46M | -18.93%1.49B | -5.10%816.95M | 6.85%1.83B |
Operating income | -44.93%292.77M | -43.91%512.67M | -7.68%531.67M | -3.38%914.01M | 92.95%575.89M | -36.39%945.96M | -63.47%298.46M | -18.93%1.49B | -5.10%816.95M | 6.85%1.83B |
Operating expenses | 52.22%-232.07M | 35.07%-483.43M | 0.92%-485.66M | 3.25%-744.57M | -139.47%-490.14M | 29.25%-769.58M | 66.97%-204.68M | 17.49%-1.09B | 3.46%-619.7M | -5.07%-1.32B |
Gross profit | 31.94%60.7M | -82.75%29.24M | -46.34%46.01M | -3.93%169.45M | -8.58%85.74M | -55.83%176.38M | -52.45%93.79M | -22.62%399.31M | -9.93%197.25M | 11.69%516.05M |
Selling expenses | 0.54%-15.46M | -14.49%-44.13M | 0.80%-15.54M | 11.16%-38.54M | 22.01%-15.67M | -10.57%-43.39M | -2.00%-20.09M | 6.32%-39.24M | 2.56%-19.7M | 4.78%-41.89M |
Administrative expenses | 1.24%-18.21M | 19.88%-46.63M | 28.09%-18.43M | -9.17%-58.2M | -5.98%-25.64M | -2.98%-53.32M | 5.42%-24.19M | 18.69%-51.77M | 3.80%-25.57M | -11.32%-63.67M |
Research and development expenses | 7.22%-9.39M | 52.35%-23.14M | 61.41%-10.12M | 1.56%-48.56M | -33.67%-26.23M | 26.19%-49.33M | 9.38%-19.63M | 19.99%-66.83M | 10.96%-21.66M | -17.22%-83.52M |
Profit from asset sales | ---- | -491.33%-67.12K | ---- | -127.67%-11.35K | 159.09%19.98K | -96.92%41.02K | -1,214.06%-33.82K | 2,017.61%1.33M | --3.04K | 274.32%62.86K |
Revaluation surplus | ---- | -84.73%1.61M | ---- | -11.44%10.54M | ---- | 49.97%11.9M | ---- | -9.52%7.93M | ---- | 111.79%8.77M |
-Changes in the fair value of other assets | ---- | -84.73%1.61M | ---- | -11.44%10.54M | ---- | 49.97%11.9M | ---- | -9.52%7.93M | ---- | 111.79%8.77M |
Impairment and provision | --22.82M | -316.56%-193.87M | ---- | 71.83%-46.54M | 881.81%10.72M | -115.91%-165.24M | 27.76%-1.37M | -52.55%-76.53M | 74.93%-1.9M | -66.35%-50.17M |
-Other impairment is provision | --22.82M | -316.56%-193.87M | ---- | 71.83%-46.54M | 881.81%10.72M | -115.91%-165.24M | 27.76%-1.37M | -52.55%-76.53M | 74.93%-1.9M | -66.35%-50.17M |
Special items of operating profit | 395.06%27.25M | -50.56%10.86M | 13.23%5.51M | -17.67%21.96M | -58.90%4.86M | 245.95%26.67M | 14.30%11.83M | -18.24%7.71M | 671.81%10.35M | -62.24%9.43M |
Adjustment items of operating profit | ---22.82M | ---- | ---- | ---- | ---- | ---- | -63.88%1.37M | ---- | --3.8M | ---- |
Operating profit | 777.74%42.44M | -6,202.55%-270.91M | -84.23%4.84M | 104.33%4.44M | -21.80%30.67M | -158.20%-102.43M | -71.89%39.22M | -38.77%176.01M | 1.46%139.5M | 2.38%287.43M |
Financing cost | -1.59%-16.82M | 37.78%-36.83M | 41.85%-16.56M | 14.15%-59.2M | -11.77%-28.48M | -1.65%-68.96M | 20.26%-25.48M | -16.98%-67.84M | -63.06%-31.95M | -145.44%-57.99M |
Special items of earning before tax | -1,769.69%-13.83K | 5,341.28%2.75M | -99.70%828.56 | -88.93%50.48K | 74.66%274.83K | 2,179.99%456.14K | 177.46%157.35K | -90.11%20.01K | -96.94%56.71K | -96.12%202.25K |
Earning before tax | 318.43%25.61M | -457.52%-305M | -574.51%-11.72M | 68.00%-54.71M | -82.23%2.47M | -258.00%-170.93M | -87.08%13.9M | -52.89%108.19M | -10.14%107.61M | -12.47%229.64M |
Tax | -66.60%375.71K | 443.10%4.14M | 221.51%1.12M | -106.42%-1.21M | 74.71%-925.82K | 172.21%18.77M | 80.54%-3.66M | 29.62%-26M | 2.33%-18.81M | 18.36%-36.94M |
After-tax profit from continuing operations | 345.16%25.98M | -438.10%-300.86M | -786.06%-10.6M | 63.25%-55.91M | -84.91%1.54M | -285.14%-152.16M | -88.47%10.24M | -57.35%82.19M | -11.93%88.8M | -8.40%192.7M |
Earning after tax | 345.16%25.98M | -438.10%-300.86M | -786.06%-10.6M | 63.25%-55.91M | -84.91%1.54M | -285.14%-152.16M | -88.47%10.24M | -57.35%82.19M | -11.64%88.8M | -11.24%192.7M |
Minority profit | 93.88%-213.43K | -920.27%-27.34M | -127.72%-3.49M | 126.06%3.33M | -498.37%-1.53M | 48.52%-12.79M | 94.85%-256.13K | -653.55%-24.84M | -518.27%-4.97M | 34.17%-3.3M |
Profit attributable to shareholders | 468.53%26.2M | -361.69%-273.53M | -330.99%-7.11M | 57.49%-59.24M | -70.68%3.08M | -230.23%-139.38M | -88.81%10.5M | -45.39%107.02M | -5.57%93.77M | -11.75%195.99M |
Basic earnings per share | 466.67%0.033 | -400.00%-0.35 | -325.00%-0.009 | 61.11%-0.07 | -69.23%0.004 | -228.57%-0.18 | -88.98%0.013 | -44.00%0.14 | -5.60%0.118 | -10.71%0.25 |
Diluted earnings per share | 466.67%0.033 | -400.00%-0.35 | -325.00%-0.009 | 61.11%-0.07 | -69.23%0.004 | -228.57%-0.18 | -88.98%0.013 | -44.00%0.14 | -5.60%0.118 | -10.71%0.25 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Lixin Certified Public Accountants (special general partnership) | -- | Lixin Certified Public Accountants (special general partnership) | -- | Lixin Certified Public Accountants (special general partnership) | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data